Pactiv Evergreen (PTVE) Stock Forecast, Price Target & Predictions
PTVE Stock Forecast
Pactiv Evergreen stock forecast is as follows: an average price target of $15.50 (represents a 19.23% upside from PTVE’s last price of $13.00) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
PTVE Price Target
The average price target for Pactiv Evergreen (PTVE) is $15.50 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $17.00 to $14.00. This represents a potential 19.23% upside from PTVE's last price of $13.00.
PTVE Analyst Ratings
According to 6 Wall Street analysts, Pactiv Evergreen's rating consensus is 'Buy'. The analyst rating breakdown for PTVE stock is 0 'Strong Buy' (0.00%), 5 'Buy' (83.33%), 1 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Pactiv Evergreen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Arun Viswanathan | RBC Capital | $17.00 | $13.57 | 25.28% | 30.77% |
| Mar 04, 2024 | Pactiv Evergreen | Goldman Sachs | $14.00 | $13.18 | 6.22% | 7.69% |
| Nov 14, 2022 | - | Goldman Sachs | $12.00 | $11.54 | 3.99% | -7.69% |
The latest Pactiv Evergreen stock forecast, released on May 06, 2024 by Arun Viswanathan from RBC Capital, set a price target of $17.00, which represents a 25.28% increase from the stock price at the time of the forecast ($13.57), and a 30.77% increase from PTVE last price ($13.00).
Pactiv Evergreen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $15.50 |
| Last Closing Price | $13.00 | $13.00 | $13.00 |
| Upside/Downside | -100.00% | -100.00% | 19.23% |
In the current month, the average price target of Pactiv Evergreen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Pactiv Evergreen's last price of $13.00. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 08, 2024 | Citigroup | Buy | Buy | Hold |
| May 06, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 06, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Apr 04, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Apr 04, 2024 | UBS | Buy | Buy | Hold |
| Apr 04, 2024 | Citigroup | Buy | Buy | Hold |
| Mar 04, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Mar 04, 2024 | UBS | Buy | Buy | Hold |
| Mar 04, 2024 | Citigroup | Buy | Buy | Hold |
| Mar 04, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Pactiv Evergreen's last stock rating was published by Citigroup on Jul 08, 2024. The company gave PTVE a "Buy" rating, the same as its previous rate.
Pactiv Evergreen Financial Forecast
Pactiv Evergreen Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.18B | $1.38B | $1.43B | $1.43B | $1.48B | $1.61B | $1.64B | $1.50B | $1.53B | $1.39B | $1.35B | $1.16B | $1.18B | $1.20B |
| Avg Forecast | $1.32B | $1.37B | $1.39B | $1.28B | $1.29B | $1.33B | $1.33B | $1.24B | $1.28B | $1.37B | $1.36B | $1.29B | $1.32B | $1.39B | $1.55B | $1.44B | $1.49B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| High Forecast | $1.34B | $1.39B | $1.41B | $1.30B | $1.31B | $1.35B | $1.35B | $1.26B | $1.29B | $1.37B | $1.36B | $1.29B | $1.33B | $1.41B | $1.57B | $1.45B | $1.51B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| Low Forecast | $1.30B | $1.35B | $1.37B | $1.27B | $1.28B | $1.32B | $1.32B | $1.23B | $1.26B | $1.37B | $1.36B | $1.29B | $1.30B | $1.37B | $1.53B | $1.42B | $1.47B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.99% | 0.92% | 1.00% | 0.99% | 1.08% | 1.02% | 1.11% | 1.03% | 1.05% | 1.10% | 1.12% | 0.97% | 1.00% |
Pactiv Evergreen's average Quarter revenue forecast for Mar 24 based on 2 analysts is $1.29B, with a low forecast of $1.29B, and a high forecast of $1.29B. PTVE's average Quarter revenue forecast represents a 9.20% increase compared to the company's last Quarter revenue of $1.18B (Dec 23).
Pactiv Evergreen EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $83.00M | $113.00M | $-80.00M | $158.00M | $160.00M | $215.00M | $256.00M | $185.00M | $51.00M | $150.00M | $131.00M | $79.00M | $342.00M | $-169.00M |
| Avg Forecast | $175.91M | $182.52M | $185.01M | $170.96M | $172.09M | $177.56M | $177.46M | $165.30M | $170.43M | $182.41M | $180.88M | $116.16M | $175.66M | $185.30M | $206.25M | $91.83M | $81.02M | $208.79M | $225.91M | $72.59M | $207.96M | $186.75M | $172.65M | $233.61M | $170.71M | $-2.93B |
| High Forecast | $177.99M | $184.68M | $187.20M | $172.98M | $174.13M | $179.66M | $179.56M | $167.25M | $172.45M | $182.54M | $180.88M | $139.40M | $177.74M | $187.49M | $208.69M | $110.20M | $97.22M | $208.79M | $225.91M | $87.11M | $207.96M | $186.75M | $172.65M | $280.34M | $170.71M | $-2.34B |
| Low Forecast | $173.83M | $180.36M | $182.82M | $168.94M | $170.05M | $175.46M | $175.36M | $163.34M | $168.41M | $182.27M | $180.88M | $92.93M | $173.58M | $183.10M | $203.81M | $73.46M | $64.82M | $208.79M | $225.91M | $58.07M | $207.96M | $186.75M | $172.65M | $186.89M | $170.71M | $-3.52B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.61% | -0.39% | 1.72% | 1.97% | 1.03% | 1.13% | 2.55% | 0.25% | 0.80% | 0.76% | 0.34% | 2.00% | 0.06% |
2 analysts predict PTVE's average Quarter EBITDA for Mar 24 to be $116.16M, with a high of $139.40M and a low of $92.93M. This is 39.96% upper than Pactiv Evergreen's previous annual EBITDA (Dec 23) of $83.00M.
Pactiv Evergreen Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $21.00M | $72.00M | $-139.00M | $-133.00M | $26.00M | $176.00M | $73.00M | $43.00M | $78.00M | - | $7.00M | $-15.00M | $236.00M | $-359.00M |
| Avg Forecast | $80.20M | $72.81M | $56.30M | $34.26M | $72.62M | $67.45M | $57.27M | $40.18M | $64.63M | $62.89M | $46.10M | $35.68M | $35.00M | $33.21M | $38.51M | $28.20M | $50.84M | $30.25M | $40.08M | $22.30M | $76.98M | $22.32M | $27.78M | $-44.36M | $44.75M | $-6.23B |
| High Forecast | $81.43M | $73.93M | $57.16M | $34.79M | $73.74M | $68.49M | $58.15M | $40.80M | $70.02M | $64.64M | $46.12M | $42.81M | $50.00M | $33.25M | $39.10M | $33.85M | $61.00M | $30.25M | $40.08M | $26.76M | $76.98M | $22.32M | $27.78M | $-35.49M | $44.75M | $-4.98B |
| Low Forecast | $78.97M | $71.69M | $55.43M | $33.73M | $71.51M | $66.42M | $56.39M | $39.57M | $59.24M | $61.15M | $46.08M | $28.54M | $20.00M | $33.17M | $37.92M | $22.56M | $40.67M | $30.25M | $40.08M | $17.84M | $76.98M | $22.32M | $27.78M | $-53.23M | $44.75M | $-7.47B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 2.17% | -3.61% | -4.72% | 0.51% | 5.82% | 1.82% | 1.93% | 1.01% | - | 0.25% | 0.34% | 5.27% | 0.06% |
Pactiv Evergreen's average Quarter net income forecast for Mar 24 is $35.68M, with a range of $28.54M to $42.81M. PTVE's average Quarter net income forecast represents a 69.90% increase compared to the company's last Quarter net income of $21.00M (Dec 23).
Pactiv Evergreen SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $133.00M | $137.00M | $136.00M | $130.00M | $148.00M | $145.00M | $148.00M | $142.00M | $-121.00M | $104.00M | $115.00M | $126.00M | $112.00M | $116.00M |
| Avg Forecast | $123.07M | $127.70M | $129.44M | $119.61M | $120.40M | $124.23M | $124.16M | $115.65M | $119.24M | $127.62M | $126.55M | $117.82M | $122.90M | $129.64M | $144.30M | $93.14M | $-192.22M | $138.29M | $149.63M | $73.63M | $137.74M | $123.70M | $114.36M | $372.60M | $113.07M | $111.34M |
| High Forecast | $124.53M | $129.21M | $130.98M | $121.03M | $121.83M | $125.70M | $125.63M | $117.02M | $120.65M | $127.71M | $126.55M | $141.39M | $124.35M | $131.18M | $146.01M | $111.77M | $-153.78M | $138.29M | $149.63M | $88.36M | $137.74M | $123.70M | $114.36M | $447.12M | $113.07M | $111.34M |
| Low Forecast | $121.62M | $126.19M | $127.91M | $118.20M | $118.98M | $122.76M | $122.69M | $114.28M | $117.83M | $127.53M | $126.55M | $94.26M | $121.45M | $128.11M | $142.59M | $74.51M | $-230.67M | $138.29M | $149.63M | $58.90M | $137.74M | $123.70M | $114.36M | $298.08M | $113.07M | $111.34M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.06% | 0.94% | 1.40% | -0.77% | 1.05% | 0.99% | 1.93% | -0.88% | 0.84% | 1.01% | 0.34% | 0.99% | 1.04% |
Pactiv Evergreen's average Quarter SG&A projection for Mar 24 is $117.82M, based on 2 Wall Street analysts, with a range of $94.26M to $141.39M. The forecast indicates a -11.41% fall compared to PTVE last annual SG&A of $133.00M (Dec 23).
Pactiv Evergreen EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.12 | $0.16 | $-0.78 | $-0.75 | $0.15 | $0.99 | $0.41 | $0.24 | $0.44 | - | $0.04 | $-0.09 | $0.10 | $-2.59 |
| Avg Forecast | $0.45 | $0.40 | $0.31 | $0.19 | $0.40 | $0.37 | $0.32 | $0.22 | $0.36 | $0.35 | $0.26 | $0.09 | $0.19 | $0.18 | $0.21 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| High Forecast | $0.45 | $0.41 | $0.32 | $0.19 | $0.41 | $0.38 | $0.32 | $0.23 | $0.39 | $0.36 | $0.26 | $0.09 | $0.28 | $0.18 | $0.22 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| Low Forecast | $0.44 | $0.40 | $0.31 | $0.19 | $0.40 | $0.37 | $0.31 | $0.22 | $0.33 | $0.34 | $0.26 | $0.09 | $0.11 | $0.18 | $0.21 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 0.87% | -3.64% | -10.21% | 2.84% | 5.92% | 1.85% | 2.30% | 1.03% | - | 0.26% | -1.31% | 0.40% | -17.61% |
According to 2 Wall Street analysts, Pactiv Evergreen's projected average Quarter EPS for Mar 24 is $0.09, with a low estimate of $0.09 and a high estimate of $0.09. This represents a -28.19% decrease compared to PTVE previous annual EPS of $0.12 (Dec 23).